Get the Stockscreener App
2.43
0.00%
0.00
Pre-market:
2.35
-0.08
-3.29%
Psyence Biomedical Ltd stock is traded at $2.43, with a volume of 8,096.
It is up +0.00% in the last 24 hours and down -5.08% over the past month.
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.
See More
Previous Close:
$2.43
Open:
$2.422
24h Volume:
8,096
Relative Volume:
0.02
Market Cap:
$5.57M
Revenue:
-
Net Income/Loss:
$1.52M
P/E Ratio:
-0.3844
EPS:
-6.3213
Net Cash Flow:
$-1.14M
1W Performance:
-4.33%
1M Performance:
-5.08%
6M Performance:
-87.34%
1Y Performance:
-91.94%
1-Day Range:
$2.3601
$2.43
1-Week Range:
$2.28
$2.59
52-Week Range:
$0.6254
$74.94
Psyence Biomedical Ltd Stock (PBM) Company Profile
Compare PBM vs VRTX, REGN, ALNY, ARGX, INSM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PBM
Psyence Biomedical Ltd
|
2.43 | 5.57M | 0 | 1.52M | -1.14M | -6.3213 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Psyence Biomedical Ltd Stock (PBM) Latest News
Investment Review: Is Psyence Biomedical Ltd Equity Warrant a cyclical or defensive stockWeekly Trade Analysis & Risk Managed Trade Strategies - baoquankhu1.vn
Trend Review: Is Psyence Biomedical Ltd Equity Warrant stock risky to hold now2026 Snapshot & Verified Momentum Stock Watchlist - baoquankhu1.vn
PBM.O Technical Analysis & Stock Price Forecast - Intellectia AI
Weekly Recap: What drives Garrett Motion Incs stock priceShare Buyback & Weekly Top Gainers Alerts - baoquankhu1.vn
Is Psyence Biomedical Ltd stock a good pick for beginners2026 Trade Ideas & Safe Entry Point Identification - baoquankhu1.vn
PBM Should I Buy - Intellectia AI
PBM Technical Analysis & Stock Price Forecast - Intellectia AI
Psyence Biomedical shares rise following equity investment agreement - MSN
Psyence Biomedical Ltd. (PBM) Achieves Breakthrough in High-Purity Ibogaine Production - MSN
Portfolio Recap: Will Psyence Biomedical Ltd Equity Warrant outperform tech stocks2026 PostEarnings & Stepwise Trade Execution Plans - baoquankhu1.vn
IPO Launch: Is Psyence Biomedical Ltd stock influenced by commodity pricesTrade Volume Report & Weekly High Return Stock Forecasts - baoquankhu1.vn
PBM Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Psyence Biomedical announces milestone in natural ibogaine HCl production - MSN
Market Recap: Can Psyence Biomedical Ltd Equity Warrant beat the S P 500Earnings Growth Report & Breakout Confirmation Alerts - baoquankhu1.vn
Energy Moves: Is Psyence Biomedical Ltd in a bullish channelTrade Risk Report & Free Risk Controlled Daily Trade Plans - baoquankhu1.vn
PBM.O PE Ratio & Valuation, Is PBM.O Overvalued - Intellectia AI
PBM News & Events - Intellectia AI
PBM Stock Price, Quote & Chart | PSYENCE BIOMEDICAL LTD (NASDAQ:PBM) - ChartMill
Big Money Moves: Is Psyence Biomedical Ltd Equity Warrant undervalued by DCF analysis2026 Review & Safe Swing Trade Setup Alerts - baoquankhu1.vn
Institution Moves: Can Psyence Biomedical Ltd Equity Warrant beat the S P 500Insider Buying & Daily Stock Momentum Reports - baoquankhu1.vn
Corporate Update: Psyence BioMed Advances Vertically Integrated Pharmaceutical Platform Following PsyLabs Export Milestone - The Manila Times
Psyence Biomedical Ltd. Strengthens Pharmaceutical-Grade Manufacturing Capabilities Through Strategic Investment in PsyLabs - Quiver Quantitative
Inside Psyence BioMed’s debt-free push into $8.75B psychedelic drugs - Stock Titan
Aug Rallies: Is 1stdibsCom Inc stock a smart retirement pick2026 PreEarnings & AI Driven Stock Reports - baoquankhu1.vn
Aug Highlights: Will Psyence Biomedical Ltd. Equity Warrant be affected by tariffs2026 Market Sentiment & Free Verified High Yield Trade Plans - baoquankhu1.vn
Death Cross: Whats the beta of Psyence Biomedical Ltd stockPortfolio Growth Summary & High Win Rate Trade Tips - baoquankhu1.vn
Can Psyence Biomedical Ltd. stock withstand economic slowdownJuly 2025 Intraday Action & Accurate Entry and Exit Point Alerts - Naître et grandir
Market Outlook: Will Psyence Biomedical Ltd Equity Warrant benefit from government policyTrade Exit Summary & Long-Term Capital Growth Ideas - baoquankhu1.vn
Aug PostEarnings: Will Psyence Biomedical Ltd outperform its industry peers2025 Trade Ideas & Precise Trade Entry Recommendations - baoquankhu1.vn
Gainers Report: Is Psyence Biomedical Ltd a top pick in the sector2025 Winners & Losers & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
How Psyence Biomedical Ltd. stock performs in interest rate cyclesWall Street Watch & High Yield Equity Trading Tips - mfd.ru
Psyence Biomed announces export of GMP-manufactured natural psilocybin (NPX-5) to Australia for ongoing clinical trial phase IIb - marketscreener.com
Psyence BioMed Announces Export of GMP-Manufactured Natural Psilocybin (NPX-5) to Australia for Ongoing Phase IIb Clinical Trial - The Manila Times
Psyence Biomedical Finalizes PsyLabs Share Swap, Settlement-Linked Loan and Board Changes - TipRanks
Large share exchange boosts Psyence Labs’ stake in Psyence Biomedical (PBM) - Stock Titan
VIX Spike: Will Psyence Biomedical Ltd Equity Warrant outperform tech stocks2025 Market Sentiment & Verified Entry Point Signals - baoquankhu1.vn
Aug EndMonth: Can Psyence Biomedical Ltd Equity Warrant beat the S P 5002025 Sector Review & Technical Pattern Based Buy Signals - baoquankhu1.vn
Will Psyence Biomedical Ltd. Equity Warrant benefit from government policyGap Down & Accurate Technical Buy Alerts - mfd.ru
PBM Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
PBM Earnings History & Surprises | EPS & Revenue Results | PSYENCE BIOMEDICAL LTD (NASDAQ:PBM) - ChartMill
PBM PE Ratio & Valuation, Is PBM Overvalued - Intellectia AI
Movement Recap: Is Psyence Biomedical Ltd Equity Warrant undervalued by DCF analysisMarket Activity Report & Community Verified Watchlist Alerts - baoquankhu1.vn
Psyence BioMed Announces Exercise Of Put Option By Psyence Labs; Stock Up - Nasdaq
Psyence Biomedical stock gains on equity investment deal By Investing.com - Investing.com Canada
PBMPsyence Biomedical Ltd. Latest Stock News & Market Updates - Stock Titan
Aug Rallies: Can Psyence Biomedical Ltd Equity Warrant outperform in the next rally2025 Trade Ideas & AI Forecast Swing Trade Picks - baoquankhu1.vn
Is Psyence Biomedical Ltd.’s ROIC above industry averageJuly 2025 Setups & Community Verified Watchlist Alerts - mfd.ru
Psyence Biomedical Shares Soar 70% Following Partner’s Ibogaine Extraction Breakthrough - MSN
Psyence BioMed Exercises Put Option to Invest in PsyLabs - Intellectia AI
Psyence Biomedical Cedes 49.98% Stake to PsyLabs in US$5 Million Share Swap - TipRanks
Psyence Biomedical Ltd. Invests in Psyence Labs Ltd. to Enhance Strategic Relationship and Supply Chain Capabilities - Quiver Quantitative
Psyence Biomedical Ltd Stock (PBM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):